Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients
- 29 August 2008
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 28 (2), 191-195
- https://doi.org/10.1007/s10096-008-0605-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Microbiology of airway disease in a cohort of patients with Cystic FibrosisBMC Infectious Diseases, 2006
- Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosisThorax, 2004
- Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis centerJournal of Cystic Fibrosis, 2004
- Pathophysiology and Management of Pulmonary Infections in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Alcaligenes infection in cystic fibrosisPediatric Pulmonology, 2002
- Factors Affecting the Incidence of Stenotrophomonas maltophilia Isolation in Cystic FibrosisChest, 2002
- Burkholderia cepacia Complex Infection in Italian Patients with Cystic Fibrosis: Prevalence, Epidemiology, and Genomovar StatusJournal of Clinical Microbiology, 2001
- Risk factors for emergence ofStenotrophomonas maltophilia in cystic fibrosisPediatric Pulmonology, 2000
- Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United StatesClinical Infectious Diseases, 1998
- The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and BritainNature Medicine, 1995